Govt bans 156 cocktail medicines that include antibiotics, painkillers and multivitamins

The government on Thursday banned 156 fixed-dose combination medicines, including antibiotics used for fever and colds, painkillers, and multivitamins, saying that they are ‘likely to involve risk to human beings’

Fixed-dose combination (FDC) drugs are medicines that contain a combination of two or more active pharmaceutical ingredients in a fixed ratio. They are also referred to as “cocktail” drugs.

Issuing a gazette notification prohibiting the manufacture, sale and distribution of these medicinesunder section 26 A of the Drugs and Cosmetics Act 1940, the Union health ministry said, “The matter was examined by an expert committee appointed by the central government and the DTAB, with both bodies recommending that there is no therapeutic justification for the ingredients contained in the said FDCs.”

The ban list includes “Aceclofenac 50mg + Paracetamol 125mg tablet.” This is one of the popular combinations of pain-relieving medicines manufactured by top pharmaceutical companies.

The list also includes Mefenamic Acid Paracetamol Injection, Cetirizine HCl Paracetamol Phenylephrine HCl, Levocetirizine Phenylephrine HCl Paracetamol, Paracetamol Chlorpheniramine Maleate Phenyl Propanolamine and Camylofin Dihydrochloride 25 mg Paracetamol 300mg.

The government also banned the combination of Paracetamol, Tramadol, Taurine and Caffeine. Tramadol is an opioid-based painkiller.

“The Central government is satisfied that the use of the Fixed Dose Combination drug is likely to involve risk to human beings whereas safer alternatives to the said drug are available,” the notification said.

It said that the matter was examined by an Expert Committee appointed by the Centre, which considered these FDCs as “irrational”.

The notification further said that “the Central government is satisfied that it is necessary and expedient in public interest to prohibit the manufacture, sale and distribution for human use of the said drug in the country”.

The list also includes certain products that many drug makers have already discontinued. In June 2023, 14 FDCs, which were part of those 344 drug combinations, were banned.

In 2016, the government announced the ban on the manufacture, sale, and distribution of 344 drug combinations after the recommendations of an expert panel set up at the Supreme Court’s behest.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks